Skip to content

4Accepted Jul 29, 4:21 PM ET

Scribe (SCTX) 10% Owner Jennifer Doudna Converts Derivatives

SCTXScribe Therapeutics, Inc.

Accepted (ET)

4:21 PM

Jul 29, 2026

Filed

Jul 29, 2026

Documents

1

Size

7.2 KB

Summary

Scribe (SCTX) 10% Owner Jennifer Doudna Converts Derivatives

Updated

What Happened

  • Jennifer A. Doudna (reported as a 10% owner) recorded conversions of derivative securities on 2026-07-27. The filing shows an acquisition of 12,511 common shares via conversion and a disposition of 74,088 common shares (both reported as conversion of a derivative security, transaction code C). No per-share prices or cash values were reported (N/A).

Key Details

  • Transaction date: 2026-07-27; Form 4 filed 2026-07-29 (timely within reporting window).
  • Conversions reported: +12,511 shares (acquired) and -74,088 shares (disposed); prices not reported.
  • Shares owned after the transactions: not provided in the excerpt of this filing.
  • Transaction code: C (conversion of derivative security).
  • Footnote (F1): Each share of Series A‑1 Preferred Stock converts into common stock on a one‑for‑0.1689 basis at the holder's option and will convert automatically upon closing of the issuer's initial public offering; the Series A‑1 has no expiration date.
  • Filing status: No late filing indicated in the provided record.

Context

  • These were conversions of preferred/derivative securities, not open‑market buys or ordinary sales. Conversions typically reflect capital-structure adjustments (preferred → common) rather than a direct insider cash purchase or routine sell signal. Because no price or cash amounts are reported here, the transaction’s dollar value and economic impact are not disclosed in this filing.

AI-written summary · check the filing